Stay updated on P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.1%
    Check dated 2024-09-04T04:13:28.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-08-13T22:30:20.000Z thumbnail image
  5. Check
    29 days ago
    No Change Detected
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version v2.10.0, adding 2 more study numbers and indicating that the study has 1 location, while the previous version v2.9.7 has been removed.
    Difference
    0.4%
    Check dated 2024-07-23T14:12:44.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T06:17:18.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-11T00:43:52.000Z thumbnail image
  9. Check
    56 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-09T23:56:35.000Z thumbnail image

Stay in the know with updates to P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the P53MVA & Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.